Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says By Reuters Stocks June 21, 2024 By Patrick Wingrove (Reuters) – Eli Lilly (NYSE:) on Friday said its popular weight-loss drug Zepbound helped resolve moderate to…